Persistent infections of mammals and mammalian cell cultures with West Nile virus

Author： Rossi Shannan L   Mason Peter W  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.3, Iss.1, 2008-01, pp. : 25-34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

West Nile Virus Vaccine.

By  

Current Drug Targets - Infectious Disorders, Vol. 1, Iss. 1, 2001-05 ,pp. : 37-50

Bentham Science Publishers

Access to resources Recommend Favorite

Immunosuppressants: West Nile virus encephalitis, status epilepticus and West Nile pneumonia (first report for daclizumab): case report

By  

Reactions Weekly, Vol. 1, Iss. 1176, 2007-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Recent developments in West Nile virus vaccine and antiviral therapy

By Woodmansee Anh N   Shi Pei-Yong  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 8, 2003-08 ,pp. : 1113-1125

Informa Healthcare

Access to resources Recommend Favorite

Novel ‘‘pseudoinfectious’’ vaccines produced against West Nile and Japanese encephalitis virus

By  

Future Virology, Vol. 3, Iss. 4, 2008-07 ,pp. : 307-309

Future Medicine

Access to resources Recommend Favorite

Viral and cellular determinants of West Nile virus entry and morphogenesis

By Chu Justin Jang-Hann   Ng Mah-Lee  

Future Virology, Vol. 3, Iss. 1, 2008-01 ,pp. : 17-23

Future Medicine

Access to resources Recommend Favorite